NCT06822790 - Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia | Biotech Hunter

Enrollment

869

Participants

Timeline

Start Date

April 9, 2025

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2028

Conditions

Hypertriglyceridemia

Interventions

DRUG

Plozasiran Injection

ARO-APOC3 injection

Trial Locations (18)

17074

RECRUITING

Research Site 8, Newport

20110

RECRUITING

Research Site 10, Manassas

21401

RECRUITING

Research Site 12, Annapolis

33014

RECRUITING

Research Site 1, Miami Lakes

33016

RECRUITING

Research Site 14, Hialeah

33321

RECRUITING

Research Site 16, Tamarac

33614

RECRUITING

Research Site 18, Tampa

60068

RECRUITING

Research Site 17, Park Ridge

65109

RECRUITING

Research Site 2, Jefferson City

68144

RECRUITING

Research Site 3, Omaha

77479

RECRUITING

Research Site 13, Sugar Land

84010

RECRUITING

Research Site 15, Bountiful

90211

RECRUITING

Research Site 9, Beverly Hills

91303

RECRUITING

Research Site 11, Canoga Park

N6A 5K8

RECRUITING

Research Site 7, London

G7H 7K9

RECRUITING

Research Site 6, Chicoutimi

H2W 1R7

RECRUITING

Research Site 5, Montreal

G1V 4W2

RECRUITING

Research Site 4, Québec